Combulin™
Combulin™
| Primary Indication | Treatment of Type 2 diabetes mellitus |
| Stage of Development | Preclinical |
- As a follow-on product to Capsulin, Diabetology is developing an oral combination therapy bringing insulin and an oral antidiabetic agent together
- Therapeutic benefit from simultaneous dosing of insulin and insulin sensitizer
Print 